Cutting the dose of Tylenol in opioids makes the drugs safer. Why? Pharma company Johnson & Johnson is developing a drug that could reduce liver damage caused by Tylenol — which J&J also sells.
Join host Cameron English as he sits down with Dr. Josh Bloom to break down these stories on Episode 42 of the Science Dispatch podcast:
Lost in the discussion of the alleged danger of opioid medications is that most of them also contain acetaminophen (Tylenol). Although acetaminophen is generally seen as benign, it is not. Here is what happened when the FDA cut the maximum acetaminophen dose to 325 mg. You may be surprised.
Johnson & Johnson is working on a drug to repair liver damage caused by Tylenol, which has made the company billions since it was launched in 1955. Isn't this a bit like having a dentist's office in the back of a candy store?
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
